Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• UBS cut Henry Schein, Inc. HSIC price target from $83 to $80. UBS analyst Kevin Caliendo maintained a Neutral rating. Henry Schein shares closed at $75.82 on Tuesday. See how other analysts view this stock.
• Piper Sandler raised the price target for Prothena Corporation plc PRTA from $94 to $110. Piper Sandler analyst Yasmeen Rahimi maintained an Overweight rating. Prothena shares closed at $14.63 on Tuesday. See how other analysts view this stock.
• Canaccord Genuity increased ZoomInfo Technologies Inc. ZI price target from $14 to $15. Canaccord Genuity analyst David Hynes maintained a Buy rating. ZoomInfo shares closed at $9.53 on Tuesday. See how other analysts view this stock.
• Goldman Sachs cut the price target for ZipRecruiter, Inc. ZIP from $9 to $8. Goldman Sachs analyst Eric Sheridan maintained a Neutral rating. ZipRecruiter shares closed at $6.73 on Tuesday. See how other analysts view this stock.
• RBC Capital raised the price target for agilon health, inc. AGL from $3 to $3.5. RBC Capital analyst Sean Dodge maintained an Outperform rating. agilon health shares closed at $3.63 on Tuesday. See how other analysts view this stock.
• Roth MKM cut Shoals Technologies Group, Inc. SHLS price target from $5 to $4.5. Roth MKM analyst Philip Shen maintained a Neutral rating. Shoals Technologies Sports shares settled at $4.2650 on Tuesday. See how other analysts view this stock.
• Oppenheimer slashed Maplebear Inc. CART price target from $65 to $60. Oppenheimer analyst Jason Helfstein maintained an Outperform rating. Maplebear Brands shares closed at $48.78 on Tuesday. See how other analysts view this stock.
• Mizuho raised Check Point Software Technologies Ltd. CHKP price target from $220 to $230. Mizuho analyst Gregg Moskowitz maintained a Neutral rating. Check Point Software shares closed at $218.63 on Tuesday.  See how other analysts view this stock.
• JP Morgan increased the price target for Jazz Pharmaceuticals plc JAZZ from $200 to $209. JP Morgan analyst Jessica Fye maintained an Overweight rating. Jazz Pharmaceuticals shares settled at $139.67 on Tuesday. See how other analysts view this stock.
• UBS increased CrowdStrike Holdings, Inc. CRWD price target from $396 to $450. UBS analyst Roger Boyd maintained a Buy rating. CrowdStrike shares closed at $379.75 on Tuesday. See how other analysts view this stock.

Read This Next:

• Nvidia Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts